Compile Data Set for Download or QSAR
Report error Found 125 Enz. Inhib. hit(s) with all data for entry = 10939
TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580014(US11485736, Compound Table 2.23)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580015(US11485736, Compound Table 2.24)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580012(US11485736, Compound Table 2.21)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580013(US11485736, Compound Table 2.22)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580018(US11485736, Compound Table 3.2)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580019(US11485736, Compound Table 3.3)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580016(US11485736, Compound Table 2.25)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580017(US11485736, Compound Table 3.1)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580087(US11485736, Compound TABLE 4.5)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580020(US11485736, Compound Table 3.4)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580021(US11485736, Compound Table 3.5)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580010(US11485736, Compound Table 2.19)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580011(US11485736, Compound Table 2.20)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580009(US11485736, Compound Table 2.18)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580086(US11485736, Compound TABLE 4.4)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580084(US11485736, Compound TABLE 4.2)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580085(US11485736, Compound TABLE 4.3)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580090(US11485736, Compound TABLE 4.8)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580091(US11485736, Compound TABLE 4.9)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580088(US11485736, Compound TABLE 4.6)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580089(US11485736, Compound TABLE 4.7)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580062(US11485736, Compound Table 3.46)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580063(US11485736, Compound Table 3.47)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580060(US11485736, Compound Table 3.44)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580061(US11485736, Compound Table 3.45)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580064(US11485736, Compound Table 3.48)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580065(US11485736, Compound Table 3.49)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580110(US11485736, Compound TABLE 4.28)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580111(US11485736, Compound TABLE 4.29)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580109(US11485736, Compound TABLE 4.27)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580112(US11485736, Compound TABLE 4.30)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580005(US11485736, Compound Table 2.14 | US11485736, Comp...)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580094(US11485736, Compound TABLE 4.12)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580095(US11485736, Compound TABLE 4.13)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580092(US11485736, Compound TABLE 4.10)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580093(US11485736, Compound TABLE 4.11)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580098(US11485736, Compound TABLE 4.16)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580099(US11485736, Compound TABLE 4.17)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580096(US11485736, Compound TABLE 4.14)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580097(US11485736, Compound TABLE 4.15)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580102(US11485736, Compound TABLE 4.20)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580103(US11485736, Compound TABLE 4.21 | US11485736, Comp...)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580100(US11485736, Compound TABLE 4.18)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580101(US11485736, Compound TABLE 4.19)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580106(US11485736, Compound TABLE 4.24)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580107(US11485736, Compound TABLE 4.25)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580103(US11485736, Compound TABLE 4.21 | US11485736, Comp...)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580022(US11485736, Compound Table 3.6)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580023(US11485736, Compound Table 3.7)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandPNGBDBM580026(US11485736, Compound Table 3.10)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

Displayed 1 to 50 (of 125 total ) | Next | Last >>
Jump to: